BRYAN KIENTZ: Open Payments
NPI 1912381526 · BROKEN ARROW, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,641 in 78 payments from 18 companies in 2025. Trend: 2023 $1,199 · 2024 $1,923 · 2025 $1,641
Food & beverage: $1,641
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 7 | $242 |
| AstraZeneca Pharmaceuticals LP | 10 | $218 |
| ABBVIE INC. | 15 | $204 |
| PFIZER INC. | 9 | $173 |
| Amgen Inc. | 5 | $123 |
| Lilly USA, LLC | 5 | $107 |
| Novartis Pharmaceuticals Corporation | 5 | $105 |
| Ardelyx, Inc. | 4 | $80 |
| Novo Nordisk Inc | 2 | $66 |
| GlaxoSmithKline, LLC. | 3 | $63 |
Products named: Leqembi, NURTEC ODT, OTEZLA, FARXIGA, LEQVIO, IBSRELA, MOUNJARO, QULIPTA.
Industry payments across OK — which companies pay providers there.
